Odyssey Health (ODYY) Research & Development (2021 - 2024)
Odyssey Health's (ODYY) quarterly Research & Development came in at -$10600.0 in Q3 2024, down 133.83% year-on-year from $31329.0 in Q3 2023, and down 124.79% quarter-over-quarter from $42765.0 in Q1 2024.
Odyssey Health (ODYY) Research & Development (2021 - 2024) Analysis & Trends
Odyssey Health's Research & Development history runs 4 years deep, the most recent figure standing at -$10600.0 for Q3 2024.
- On a quarterly basis, Research & Development fell 133.83% year-over-year to -$10600.0 in Q3 2024; TTM through Apr 2025 was -$10600.0, a 110.92% decrease from a year earlier, with the FY2024 full-year figure at $55166.0, down 72.6% from the prior year.
- Research & Development slipped to -$10600.0 in Q3 2024 per ODYY's latest filing, from $42765.0 in the prior quarter.
- Across five years, Research & Development topped out at $1.0 million in Q3 2021 and bottomed at -$10600.0 in Q3 2024.
- The 4-year median for Research & Development is $63139.0 (2022), against an average of $261093.5.
- Biggest YoY gain for Research & Development was 999.64% in 2024; the steepest drop was 133.83% in 2024.
- Year by year, Research & Development stood at $322504.0 in 2021, then advanced by 9.83% to $354215.0 in 2022, then sank by 93.51% to $23001.0 in 2023, then plunged by 146.08% to -$10600.0 in 2024.
- Per Business Quant, the three latest ODYY Research & Development figures stand at -$10600.0 (Q3 2024), $42765.0 (Q1 2024), and $23001.0 (Q4 2023).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -461.27 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Odyssey Health | 1.08 Mn | 782,508.17 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2024 | -10,600.00 |
| Jan 31, 2024 | 42,765.00 |
| Oct 31, 2023 | 23,001.00 |
| Jul 31, 2023 | 31,329.00 |
| Jan 31, 2023 | 3,889.00 |
| Oct 31, 2022 | 354,215.00 |
| Jul 31, 2022 | 470,658.00 |
| Apr 30, 2022 | 63,139.00 |
| Jan 31, 2022 | 460,723.00 |
| Oct 31, 2021 | 322,504.00 |
| Jul 31, 2021 | 1.02 Mn |
| Apr 30, 2021 | 565,764.00 |
| Jan 31, 2021 | 42,619.00 |